Innovate Corp(VATE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.84 | Insider Own | 64.03% | Shs Outstand | 13.6M | Perf Week | -1.61% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 4.9M | Perf Month | -25.84% |
| Enterprise Value | 0.69B | PEG | - | EPS next Q | - | Inst Own | 27.92% | Short Float | 11.35% | Perf Quarter | -24.52% |
| Income | -0.02B | P/S | 0.05 | EPS this Y | - | Inst Trans | 26.01% | Short Ratio | 1.51 | Perf Half Y | -53.31% |
| Sales | 1.52B | P/B | - | EPS next 5Y | - | ROA | -2.36% | Short Interest | 0.56M | Perf YTD | 34.12% |
| Book/sh | -17.83 | P/C | 0.86 | EPS past 3/5Y | 2.52% 13.79% | ROE | - | 52W High | -74.13% ($21.30) | Perf Year | 14.82% |
| Cash/sh | 6.44 | P/FCF | 0.71 | Sales past 3/5Y | -8.7% 11.69% | ROIC | - | 52W Low | 61.66% ($3.41) | Perf 3Y | -51.89% |
| Dividend Est. | - | EV/EBITDA | 6.98 | EPS Y/Y TTM | 70.1% | Gross Margin | 14.85% | Volatility(W/M) | 7.05% 6.09% | Perf 5Y | -84.65% |
| Dividend TTM | - | EV/Sales | 0.46 | Sales Y/Y TTM | 52.38% | Oper. Margin | 4.6% | ATR (14) | 0.42 | Perf 10Y | -85.18% |
| Dividend Ex-Date | 2013/8/28 | Quick Ratio | 0.43 | EPS Q/Q | 144.5% | Profit Margin | -1.58% | RSI (14) | 31.43 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.44 | Sales Q/Q | 74.21% | SMA20 | -12.25% ($6.28) | Beta | 2.72 | Target Price | $8.49 |
| Payout | - | Debt/Eq | - | Earnings | 2026/8/6 | SMA50 | -21.51% ($7.02) | Rel Volume | 0.36 | Prev Close | $5.8 |
| Employees | 3738 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -37.36% ($8.8) | Avg Volume(3M) | 0.37M | Price | $5.51 |
| IPO | 2009/7/13 | Option/Short | No/Yes | Trades | 947 | Volume | 132,474 | Change | -5% |
🏗️ Innovate, trading under the ticker VATE, is a diversified holding company with three segments: infrastructure, life sciences, and broadcast spectrum. At its core is the infrastructure segment, which handles structural steel fabrication and industrial construction and has been steadily building a solid backlog of projects across major U.S. cities. Medical diagnostic technology and broadcast assets are added on top of this, creating a business portfolio whose segments are largely uncorrelated with one another.
Over the past 1 year, on the lower side
74% below its 1-year high.
Traded less than usual. That is 36% of its average volume.
VATE keeps an operating profit but posts a net loss
Of every $100 in sales, $4.60 is kept as operating profit.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $5. Peers typically go for $127.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -84.7%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 27.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #39 of 51 in the industry
Based on market cap of $75M.
FAQ
What kind of company is VATE?
VATE belongs to the Industrials sector and operates in the Engineering & Construction industry.
What is the market cap of VATE?
The market cap of VATE is approximately $75M, ranking 4,637 within its sector.
What is the 52-week high and low for VATE?
VATE has recorded a 52-week high of $21.30 and a low of $3.41.